/>

Wednesday, June 19, 2019

NEWS 19 June 2019

NEWS FROM USA

505(b)2 APPROVAL

 

Approval Date

Product Name

NDA Sponsor

Brand Name

Prescribing information

13 June 2019

Budesonide ER capsules

(6 mg and 9 mg)

Sun Pharma

Ortikos

Link

 

 

NEW EXCLUSIVITY LISTINGS IN THE ORANGE BOOK

 

New PC (Patent Challenge) exclusivity listing in the orange book

Drug

Applicant

Corresponding RLD

PC exclusivity expiration date

Other TA holders

Erlotinib hydrochloride tablets

Mylan

Tarceva

(OSI)

5 Nov. 2019

Natco

 

New CGT (competitive generic therapy) exclusivity listing in the orange book

Drug

Applicant

Corresponding RLD

CGT exclusivity expiration date

Sildenafil powder for oral suspension

Novitium

Revatio

(Pfizer)

27 Nov. 2019

 

NEW PARAGRAPH IV FILING

DRUG

Dosage form

Corresponding RLD

Date of Submission

Type of Submission (Based on Date)

Halobetasol Propionate

Lotion 0.01%

Bryhali

(Bausch)

20 Mar. 2019

Open First to File#

Gabapentin Enacarbil

Extended-release Tablets

Horizant

29 April 2019

Open First to File

#NDA of Bryhali was approved by USFDA on 6 Nov. 2018. First Para IV filing was done within 4 and half months of FDA approval.

Full list of Paragraph IV Patent certifications: Link

505(b)2 IN PIPELINE

Lamotrigine oral liquid (Eton/Aucta pharma):  Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application.

-      Eton Pharmaceuticals, Inc has entered into an agreement with Aucta Pharmaceuticals, Inc to acquire U.S. marketing rights for ET-105.

-      Aucta pharma submitted the product’s New Drug Application (NDA) to the FDA in May 2019.

-      Lamotrigine is currently only approved in tablet formulations, and Eton believes ET-105 will fulfill a significant unmet need for pediatric patients requiring precision dosing.

-      Full Press Release: Link

 

ANDA APPROVALS

 

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

12 June 2019

Paliperidone ER tablets

Inventia

Invega

(Janssen)

Three

12 June 2019

Loratidine chewable tablets

Perrigo

Children’s Claritin

(Bayer)

One

(Sun)

12 June 2019

Vancomycin injection

Hainan polypharma

Vancocin (Baxter)

Ten

13 June 2019

Dorzolamide, Timolol ophthalmic drops

FDC

Cosopt

(Oak pharma)

Seven

14 June 2019

Diltiazem ER capsules

Novast

Cardizem CD

(Bausch)

Seven

14 June 2019

Omega-3 acid ethyl ester

Zydus

Lovaza

(Smithkline Beecham)

Six

17 June 2019

Potassium chloride ER tablets

PII

K-tab

(Abbvie)

One

(Virtuvias)

18 June 2019

Diclofenac sodium 37.5 mg/ml

Mylan

Dyloject

(javelin)

None

 

If you have any query/suggestion then please write us at pharmacaption@gmail.com

No comments:

Post a Comment